Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.

To evaluate the technologies used to reduce anthracycline-induced cardiotoxicity in children. Also to evaluate cardiac markers to quantify cardiotoxicity, and identify cost-effectiveness studies and future research priorities.